📈 MLTX Spike
September 29, 2025
Open Price
${{Model.Record.Open.ToString("0.00")}}
Close Price
${{Model.Record.Close.ToString("0.00")}}
Previous Close
${{Model.Record.PrevClose.ToString("0.00")}}
% Change
+-89.93%
📊Price Chart (14 Days)
📰Related News
12 articles
Reported Sunday, MoonLake Phase 3 VELA Trials Show Sonelokimab Achieves Statistically Significant HiSCR75 Responses In Moderate To Severe Hidradenitis Suppurativa
benzinga • Sep 29, 2025 06:35 UTC
Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
benzinga • Sep 29, 2025 09:07 UTC
BTIG Downgrades MoonLake to Neutral, Maintains Price Target to $85
benzinga • Sep 29, 2025 10:25 UTC
MoonLake Immunotherapeutics Reported Sunday On Their Hidradenitis Suppurativa Program, In VELA-2, Intercurrent Events In The Higher-than-expected Placebo Arm Precluded The Study From Achieving Statistical Significance In The Week 16 Primary Endpoint Using Composite Strategy
benzinga • Sep 29, 2025 10:48 UTC
This Electronic Arts Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
benzinga • Sep 29, 2025 11:52 UTC
Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
benzinga • Sep 29, 2025 12:06 UTC
12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga • Sep 29, 2025 12:09 UTC
RBC Capital Downgrades MoonLake to Sector Perform, Lowers Price Target to $10
benzinga • Sep 29, 2025 13:43 UTC
Nasdaq Jumps 150 Points; US Pending Home Sales Rise
benzinga • Sep 29, 2025 14:11 UTC
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga • Sep 29, 2025 17:06 UTC
Crude Oil Falls Sharply; Carnival Posts Upbeat Earnings
benzinga • Sep 29, 2025 17:14 UTC
MoonLake's Immunotherapeutics Stock Plummets After Phase 3 Data Readouts
benzinga • Sep 29, 2025 18:45 UTC
🤖AI Classification
Classify news articles to understand market sentiment